Ruedi Wealth Management’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-52
Closed -$4.58K 141
2025
Q1
$4.58K Hold
52
﹤0.01% 218
2024
Q4
$4.75K Hold
52
﹤0.01% 217
2024
Q3
$5.82K Sell
52
-57
-52% -$5.7K ﹤0.01% 205
2024
Q2
$10.7K Buy
109
+57
+110% +$5.66K ﹤0.01% 176
2024
Q1
$5.21K Hold
52
﹤0.01% 196
2023
Q4
$4.67K Hold
52
﹤0.01% 173
2023
Q3
$3.99K Hold
52
﹤0.01% 163
2023
Q2
$4.35K Hold
52
﹤0.01% 168
2023
Q1
$4.38K Hold
52
﹤0.01% 198
2022
Q4
$4.23K Buy
+52
New +$4.19K ﹤0.01% 185

Other funds holding EMN

Ruedi Wealth Management's EMN Position: Q2 2025 in Review

Ruedi Wealth Management sold out of Eastman Chemical (EMN) in Q2 2025, closing a stake of 52 shares — an estimated $4.58K sold.

Ruedi Wealth Management first reported a position in EMN in Q4 2022 and held it in 10 quarters. The position peaked at $10.7K in Q2 2024. 751 funds tracked by Wall St. Rank hold EMN as of Q2 2025.

  • Ruedi Wealth Management reported no remaining Eastman Chemical position as of Q2 2025 after selling out during the quarter.
  • Ruedi Wealth Management sold 52 Eastman Chemical shares in Q2 2025, an estimated $4.58K.
  • Ruedi Wealth Management first reported a position in Eastman Chemical in Q4 2022 and held it in 10 quarters.
  • Ruedi Wealth Management's Eastman Chemical position peaked at $10.7K in Q2 2024.
  • 751 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2025.

Based on Ruedi Wealth Management's 13F filing for Q2 2025, filed 25 Jul 2025.